TELA
TELA Bio, Inc. NASDAQ Listed Nov 8, 2019$0.82
After hrs
$0.80
+0.00%
Mkt Cap $36.8M
52w Low $0.50
19.0% of range
52w High $2.20
50d MA $0.84
200d MA $1.06
P/E (TTM)
-1.0x
EV/EBITDA
—
P/B
6.1x
Debt/Equity
8.8x
ROE
-615.1%
P/FCF
-1.4x
RSI (14)
46.70
ATR (14)
$0.10
Beta
0.99
50d MA
$0.84
200d MA
$1.06
Avg Volume
139.8K
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
1 Great Valley Parkway · Malvern, PA 19355 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | AMC | -0.18 | -0.16 | +11.1% | 0.69 | -2.9% | +8.1% | -10.2% | -15.7% | +9.8% | -8.3% | — |
| Nov 13, 2025 | AMC | -0.17 | -0.19 | -11.8% | 1.11 | -5.4% | -10.0% | +14.1% | +3.5% | -8.5% | -1.9% | — |
| Aug 11, 2025 | AMC | -0.18 | -0.22 | -22.2% | 1.86 | -4.8% | -14.0% | -8.1% | +8.8% | -1.2% | +7.6% | — |
| May 8, 2025 | AMC | -0.21 | -0.25 | -19.0% | 0.99 | +1.0% | +9.0% | -6.5% | -3.0% | +1.0% | -1.0% | — |
| Mar 20, 2025 | AMC | -0.24 | -0.23 | +4.2% | 2.34 | -18.8% | -37.2% | -4.8% | -11.4% | +4.0% | +6.2% | — |
| Nov 7, 2024 | AMC | -0.37 | -0.42 | -13.5% | 2.99 | -2.7% | +3.0% | -4.5% | +5.8% | -1.6% | -0.7% | — |
| Aug 12, 2024 | AMC | -0.45 | -0.51 | -13.3% | 4.01 | -20.2% | -22.9% | -1.9% | +1.3% | +1.3% | -1.3% | — |
| May 9, 2024 | AMC | -0.48 | -0.23 | +52.1% | 4.94 | +9.9% | +16.8% | +0.5% | +0.3% | +2.7% | +6.4% | — |
| Mar 21, 2024 | AMC | -0.44 | -0.53 | -20.5% | 5.35 | +4.5% | +7.1% | -5.1% | +2.2% | +0.9% | +1.1% | — |
| Nov 9, 2023 | AMC | -0.52 | -0.45 | +13.5% | 5.73 | -12.7% | -19.4% | -2.6% | +0.9% | +5.7% | -1.0% | — |
| Aug 9, 2023 | AMC | -0.58 | -0.46 | +20.7% | 9.07 | -2.9% | -3.3% | +2.4% | +1.3% | -0.7% | -0.4% | — |
| May 11, 2023 | AMC | -0.51 | -0.63 | -23.5% | 9.96 | -1.8% | -3.7% | -1.1% | -0.1% | +2.0% | -0.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27 | Citizens | Maintains | Market Outperform → Market Outperform | — | $0.75 | $0.73 | -2.7% | -10.2% | -15.7% | +9.8% | -8.3% | +5.0% |
| Mar 25 | Piper Sandler | Maintains | Neutral → Neutral | — | $0.76 | $0.76 | -0.0% | -9.4% | +8.1% | -10.2% | -15.7% | +9.8% |
| Mar 25 | Lake Street | Maintains | Buy → Buy | — | $0.76 | $0.76 | -0.0% | -9.4% | +8.1% | -10.2% | -15.7% | +9.8% |
| Mar 25 | Canaccord Genuity | Maintains | Buy → Buy | — | $0.76 | $0.76 | -0.0% | -9.4% | +8.1% | -10.2% | -15.7% | +9.8% |
| Dec 1 | Lake Street | Maintains | Buy → Buy | — | $1.15 | $1.16 | +0.9% | -1.7% | +0.9% | +0.9% | -0.9% | +0.9% |
| Nov 18 | Canaccord Genuity | Maintains | Buy → Buy | — | $1.14 | $1.23 | +7.9% | +3.5% | -8.5% | -1.9% | +10.4% | -2.6% |
| Nov 14 | Citizens | Maintains | Market Outperform → Market Outperform | — | $1.11 | $1.05 | -5.4% | -10.0% | +14.1% | +3.5% | -8.5% | -1.9% |
| Nov 14 | Piper Sandler | Maintains | Neutral → Neutral | — | $1.11 | $1.05 | -5.4% | -10.0% | +14.1% | +3.5% | -8.5% | -1.9% |
| Mar 21 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.34 | $1.90 | -18.8% | -37.2% | -4.8% | -11.4% | +4.0% | +6.2% |
| Mar 21 | Citizens Capital Markets | Maintains | Market Outperform → Market Outperform | — | $2.34 | $1.90 | -18.8% | -37.2% | -4.8% | -11.4% | +4.0% | +6.2% |
| Mar 21 | Piper Sandler | Downgrade | Overweight → Neutral | — | $2.34 | $1.90 | -18.8% | -37.2% | -4.8% | -11.4% | +4.0% | +6.2% |
| Nov 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.99 | $2.91 | -2.7% | +3.0% | -4.5% | +5.8% | -1.6% | -0.7% |
| Oct 4 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.52 | $2.53 | +0.4% | +7.1% | -3.0% | -4.6% | -2.8% | -2.1% |
| Aug 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $4.01 | $3.20 | -20.2% | -22.9% | -1.9% | +1.3% | +1.3% | -1.3% |
| Aug 13 | Lake Street | Maintains | Buy → Buy | — | $4.01 | $3.20 | -20.2% | -22.9% | -1.9% | +1.3% | +1.3% | -1.3% |
| Aug 13 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $4.01 | $3.20 | -20.2% | -22.9% | -1.9% | +1.3% | +1.3% | -1.3% |
| Aug 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $4.01 | $3.20 | -20.2% | -22.9% | -1.9% | +1.3% | +1.3% | -1.3% |
| Jul 25 | Canaccord Genuity | Maintains | Buy → Buy | — | $4.58 | $4.60 | +0.4% | -1.7% | +2.2% | -1.1% | -2.6% | +0.5% |
| May 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $4.94 | $5.43 | +9.9% | +16.8% | +0.5% | +0.3% | +2.7% | +6.4% |
| Mar 22 | Piper Sandler | Maintains | Overweight → Overweight | — | $5.35 | $5.59 | +4.5% | +7.1% | -5.1% | +2.2% | +0.9% | +1.1% |
| Mar 22 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $5.35 | $5.59 | +4.5% | +7.1% | -5.1% | +2.2% | +0.9% | +1.1% |
| Dec 27 | Lake Street | Maintains | Buy → Buy | — | $6.52 | $6.57 | +0.8% | -3.5% | +0.3% | +4.9% | +0.0% | -0.2% |
| Nov 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $5.73 | $5.00 | -12.7% | -19.4% | -2.6% | +0.9% | +5.7% | -1.0% |
| Mar 28 | Canaccord Genuity | Maintains | Buy → Buy | — | $10.49 | $10.35 | -1.3% | +3.3% | +1.8% | +1.9% | -5.3% | +3.3% |
| Mar 22 | JMP Securities | Maintains | Market Outperform → Outperform | — | $10.49 | $10.50 | +0.1% | -5.9% | +1.4% | +0.4% | +4.4% | +3.3% |
| Nov 10 | Piper Sandler | Maintains | Overweight → Overweight | — | $6.50 | $7.01 | +7.8% | +24.6% | +0.1% | -2.3% | +2.3% | -1.2% |
| Nov 10 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $6.50 | $7.01 | +7.8% | +24.6% | +0.1% | -2.3% | +2.3% | -1.2% |
| Aug 13 | Piper Sandler | Maintains | Overweight → Overweight | — | $13.13 | $13.79 | +5.0% | +5.9% | -5.5% | +4.5% | -1.0% | -0.7% |
| Jul 9 | Jefferies | Maintains | Buy → Buy | — | $13.21 | $13.90 | +5.2% | -1.2% | +3.6% | -2.2% | +4.5% | +2.8% |
| Jun 18 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $19.91 | $20.00 | +0.5% | +8.8% | +4.3% | -7.6% | +1.9% | -6.6% |
| Jun 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $16.82 | $17.49 | +4.0% | -1.8% | +3.0% | -0.8% | +8.4% | +4.9% |
| May 13 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $11.01 | $11.86 | +7.7% | +8.7% | -2.0% | +0.9% | +7.8% | +11.8% |
| Dec 3 | Canaccord Genuity | Maintains | Buy → Buy | — | $12.31 | $12.65 | +2.8% | +5.3% | +1.4% | -8.1% | +2.5% | -1.8% |
| Dec 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $12.31 | $12.65 | +2.8% | +5.3% | +1.4% | -8.1% | +2.5% | -1.8% |
| Dec 3 | JMP Securities | Maintains | Market Outperform → Outperform | — | $12.31 | $12.65 | +2.8% | +5.3% | +1.4% | -8.1% | +2.5% | -1.8% |
| Dec 3 | Jefferies | Maintains | Buy → Buy | — | $12.31 | $12.65 | +2.8% | +5.3% | +1.4% | -8.1% | +2.5% | -1.8% |
No insider trades available.
8-K · 5.02
!!! Very High
TELA Bio, Inc. -- 8-K 5.02: Executive Change
TELA Bio appointed Doug Evan and Joseph Capper as independent directors, strengthening board governance and potentially signaling confidence in the company's strategic direction.
Apr 30
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
This 8-K filing contains minimal substantive disclosure—just procedural exhibit references—suggesting Tela either made routine announcements or the company chose minimal required disclosure, warranting scrutiny of actual exhibits for material news.
Mar 24
8-K
Unknown — 8-K Filing
TELA's stock price has fallen below Nasdaq's $1 minimum bid requirement, threatening its listing unless the company successfully appeals or reverses the decline within 180 days.
Mar 20
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Essex Woodlands Management, Inc. | 7,714,709 | $5M | — | Mar 2026 |
| 2 | Silverarc Capital Management, Llc | 2,647,512 | $3M | Reduced | Dec 2025 |
| 3 | Stonepine Capital Management, Llc | 2,617,252 | $2M | Added | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 1,540,624 | $955K | New | Mar 2026 |
| 5 | Citigroup Inc | 750,000 | $885K | — | Dec 2025 |
| 6 | Ubs Group Ag | 1,059,524 | $657K | Reduced | Mar 2026 |
| 7 | Up Strategic Wealth Investment Advisors Llc | 99,888 | $110K | — | Mar 2026 |
| 8 | Northern Trust Corp | 174,398 | $108K | — | Mar 2026 |
| 9 | Pnc Financial Services Group, Inc. | 53,612 | $33K | — | Mar 2026 |
| 10 | Renaissance Technologies Llc | 52,600 | $33K | Reduced | Mar 2026 |
| 11 | Raymond James Financial Inc | 49,700 | $31K | Added | Mar 2026 |
| 12 | Ducere Wealth Management Llc | 20,000 | $24K | New | Dec 2025 |
| 13 | Great Valley Advisor Group, Inc. | 19,602 | $23K | New | Dec 2025 |
| 14 | Hightower Advisors, Llc | 10,352 | $12K | — | Dec 2025 |
| 15 | Acadian Asset Management Llc | 20,817 | $12K | — | Mar 2026 |
| 16 | Morgan Stanley | 4,438 | $5K | — | Dec 2025 |
| 17 | Wells Fargo & Company/mn | 4,200 | $3K | New | Mar 2026 |
| 18 | Steward Partners Investment Advisory, Llc | 1,991 | $1K | — | Mar 2026 |
| 19 | Bnp Paribas Financial Markets | 214 | $133 | Added | Mar 2026 |
| 20 | Simplex Trading, Llc | 143 | $88 | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 10
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | Fidelity Extended Market Index Fund | 171,791 | $149K | Feb 2026 |
| 2 | Jacob Small Cap Growth Fund | 147,000 | $128K | Feb 2026 |
| 3 | Jacob Discovery Fund | 119,775 | $104K | Feb 2026 |
| 4 | Fidelity Total Market Index Fund | 66,813 | $58K | Feb 2026 |
| 5 | iShares Micro-Cap ETF | 85,720 | $53K | Mar 2026 |
| 6 | Perkins Discovery Fund | 64,000 | $40K | Mar 2026 |
| 7 | Fidelity Series Total Market Index Fund | 41,584 | $36K | Feb 2026 |
| 8 | Small Cap Core Fund | 33,961 | $21K | Mar 2026 |
| 9 | Fidelity Nasdaq Composite Index Fund | 18,634 | $16K | Feb 2026 |
| 10 | Knights of Columbus U.S. ALL CAP INDEX FUND | 179 | $179 | Jan 2026 |
Valuation
Market Cap
$36.8M
Enterprise Value
$45.1M
P/E (TTM)
-1.04x
Forward P/E
—
PEG Ratio
0.04x
P/B
6.12x
P/S
0.48x
P/FCF
-1.41x
EV/EBITDA
—
Shares Out
46.9M
Financials (TTM)
Revenue
$80.3M
Net Income
-$38.8M
EBITDA
-$33.8M
Free Cash Flow
-$28.7M
Op Cash Flow
-$28.2M
EPS Basic
$-0.83
EPS Diluted
$-0.83
EPS Forward
$-0.66
Gross Margin
67.7%
Op Margin
-42.0%
Net Margin
-48.4%
Balance Sheet
Total Assets
$81.4M
Total Liab.
$75.1M
Total Equity
$6.3M
Cash
$50.8M
LT Debt
$55.7M
Book Value/Sh
$0.13
Debt/Equity
8.82x
Current Ratio
4.20
Quick Ratio
3.59
Returns & Growth
ROE
-615.1%
ROA
-47.7%
ROIC
-53.2%
Rev Growth YoY
+15.8%
EPS Growth YoY
+37.6%
Price Returns
2W
-2.0%
1M
+10.9%
3M
+11.7%
6M
-15.7%
12M
-30.2%
Technicals
52W High
$2.20
52W Low
$0.50
50d MA
$0.84
200d MA
$1.06
RSI (14)
46.70
ATR (14)
$0.10
Beta
0.99
Avg Volume
140K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$2.42
High
$3.00
Low
$1.25
Median
$3.00
Data updated apr 27, 2026 4:24am
· Source: financialmodelingprep.com